163 related articles for article (PubMed ID: 27697838)
1. Estimation after blinded sample size reassessment.
Posch M; Klinglmueller F; König F; Miller F
Stat Methods Med Res; 2018 Jun; 27(6):1830-1846. PubMed ID: 27697838
[TBL] [Abstract][Full Text] [Related]
2. Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels.
Żebrowska M; Posch M; Magirr D
Stat Med; 2016 May; 35(12):1972-84. PubMed ID: 26694878
[TBL] [Abstract][Full Text] [Related]
3. Precision of maximum likelihood estimation in adaptive designs.
Graf AC; Gutjahr G; Brannath W
Stat Med; 2016 Mar; 35(6):922-41. PubMed ID: 26459506
[TBL] [Abstract][Full Text] [Related]
4. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
Mütze T; Friede T
Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
[TBL] [Abstract][Full Text] [Related]
5. Blinded and unblinded internal pilot study designs for clinical trials with count data.
Schneider S; Schmidli H; Friede T
Biom J; 2013 Jul; 55(4):617-33. PubMed ID: 23703749
[TBL] [Abstract][Full Text] [Related]
6. Blinded sample size recalculation in clinical trials with binary composite endpoints.
Sander A; Rauch G; Kieser M
J Biopharm Stat; 2017; 27(4):705-715. PubMed ID: 27295402
[TBL] [Abstract][Full Text] [Related]
7. Sample size reassessment in non-inferiority trials. Internal pilot study designs with ANCOVA.
Friede T; Kieser M
Methods Inf Med; 2011; 50(3):237-43. PubMed ID: 20213039
[TBL] [Abstract][Full Text] [Related]
8. Clinical trials with nested subgroups: Analysis, sample size determination and internal pilot studies.
Placzek M; Friede T
Stat Methods Med Res; 2018 Nov; 27(11):3286-3303. PubMed ID: 29298604
[TBL] [Abstract][Full Text] [Related]
9. Two-stage sample size re-estimation based on a nuisance parameter: a review.
Proschan MA
J Biopharm Stat; 2005; 15(4):559-74. PubMed ID: 16022163
[TBL] [Abstract][Full Text] [Related]
10. Sample size recalculation in internal pilot study designs: a review.
Friede T; Kieser M
Biom J; 2006 Aug; 48(4):537-55. PubMed ID: 16972704
[TBL] [Abstract][Full Text] [Related]
11. Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis.
Friede T; Kieser M
Pharm Stat; 2011; 10(1):8-13. PubMed ID: 19943322
[TBL] [Abstract][Full Text] [Related]
12. Sample size re-estimation incorporating prior information on a nuisance parameter.
Mütze T; Schmidli H; Friede T
Pharm Stat; 2018 Mar; 17(2):126-143. PubMed ID: 29181869
[TBL] [Abstract][Full Text] [Related]
13. Variance estimation in clinical studies with interim sample size re-estimation.
Miller F
Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
[TBL] [Abstract][Full Text] [Related]
14. Issues in designing flexible trials.
Posch M; Bauer P; Brannath W
Stat Med; 2003 Mar; 22(6):953-69. PubMed ID: 12627412
[TBL] [Abstract][Full Text] [Related]
15. Adaptive clinical trial designs with blinded selection of binary composite endpoints and sample size reassessment.
Roig MB; Melis GG; Posch M; Koenig F
Biostatistics; 2023 Dec; 25(1):237-252. PubMed ID: 36150142
[TBL] [Abstract][Full Text] [Related]
16. Sample size reestimation and Bayesian predictive probability for single-arm clinical trials with a time-to-event endpoint using Weibull distribution with unknown shape parameter.
Waleed M; He J; Phadnis MA
J Biopharm Stat; 2024 Jul; 34(4):469-487. PubMed ID: 37545144
[TBL] [Abstract][Full Text] [Related]
17. Distribution of the two-sample t-test statistic following blinded sample size re-estimation.
Lu K
Pharm Stat; 2016 May; 15(3):208-15. PubMed ID: 26865383
[TBL] [Abstract][Full Text] [Related]
18. A simple and flexible graphical approach for adaptive group-sequential clinical trials.
Sugitani T; Bretz F; Maurer W
J Biopharm Stat; 2016; 26(2):202-16. PubMed ID: 25372071
[TBL] [Abstract][Full Text] [Related]
19. Blinded sample size re-estimation in superiority and noninferiority trials: bias versus variance in variance estimation.
Friede T; Kieser M
Pharm Stat; 2013; 12(3):141-6. PubMed ID: 23509095
[TBL] [Abstract][Full Text] [Related]
20. Sample size adaptation in fixed-dose combination drug trial.
James Hung HM; Wang SJ
J Biopharm Stat; 2012; 22(4):679-86. PubMed ID: 22651108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
